Luxembourg Institute of Health
🇱🇺Luxembourg
- Country
- 🇱🇺Luxembourg
- Ownership
- -
- Established
- 2015-01-01
- Employees
- -
- Market Cap
- -
- Website
- https://www.lih.lu
New Sustained-Release Flucytosine Enters Phase II Trials for Cryptococcal Meningitis Amid HIV Funding Crisis
• A new sustained-release formulation of flucytosine for cryptococcal meningitis has entered Phase II trials in Malawi and Tanzania, simplifying dosing from four times to twice daily and improving administration options.
• Cryptococcal meningitis, the second leading cause of death in patients with advanced HIV after tuberculosis, killed approximately 130,000 people in Africa in 2023 alone.
• Recent HIV funding cuts threaten to reverse decades of progress, with experts warning of imminent stockouts of essential medicines like flucytosine and disruptions to advanced HIV disease services.
© Copyright 2025. All Rights Reserved by MedPath